Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes

OBJECTIVE—Regulatory T-cells (Tregs) have catalyzed the field of immune regulation. However, translating Treg-based therapies from animal models of autoimmunity to human clinical trials requires robust methods for the isolation and expansion of these cells—a need forming the basis for these studies....

Descripción completa

Detalles Bibliográficos
Autores principales: Putnam, Amy L., Brusko, Todd M., Lee, Michael R., Liu, Weihong, Szot, Gregory L., Ghosh, Taumoha, Atkinson, Mark A., Bluestone, Jeffrey A.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Immunology and Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646064/
https://www.ncbi.nlm.nih.gov/pubmed/19074986
http://dx.doi.org/10.2337/db08-1168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646064/
https://www.ncbi.nlm.nih.gov/pubmed/19074986
http://dx.doi.org/10.2337/db08-1168

Ejemplares similares